Citation: | Wang Huimin, Liao Meilin, Chen Yurong, et al. The Response Rate of High Dose Epirubicin in Comparison with Conventional Dose on NSCLC[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 133-135. |
[1] |
Weiss RB.The anthracyclines:Wil we ever find a better do xorubicin ? Semis Onceh 1992, 19(6):670
|
[2] |
Rosen HR,Minow RA,Leier CV,et al.Epirubicin and Doxorrubicin:A comparison of the characteristic therapeutic activity and toxicity.Cancer Treat Rev,1993,19(3):197
|
[3] |
林震琼,徐昌文,等.小细胞肺癌化疗后的病理学观察--附48例分析.中华肿瘤杂志,1988, 6(10):452-454
|
[4] |
Martoni A,Melotti B, et al. High-dose epirubicin for untreated patients with advanced tumours a phase I study.Eur-J-Cancer,1990, 26(11-12):1137-1140
|
[5] |
Cersoimo RJ,et al.Epirubicin:a review of the pliarmacology,clinical activity,and adverse effects of anadriamvcin anabgue.,J-Clim-On-col, 1986,4:425-439
|
[6] |
Martoni A, et al.Activiy of high dose epimbicin in advanced non-small-cell lung Cancer. Eur-J-Cancer,1991, 27(10):1231-1234
|
[7] |
Martoiu A. Guaraldi M, et al.A phrase II study of high- dose epirubici plus cisplatinum in advanced non-small-cell lung cancer (NSCLC),Ann-oncol 1992, 12,3(10):864-866
|
[1] | HE Huocong, SU Ying, LIN Shaojun, ZOU Changyan, LIN Keyu, PAN Jianru, CHEN Chao. Study on Annexin A2 Interacting Proteins in Nasopharyngeal Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2017, 44(2): 88-93. DOI: 10.3971/j.issn.1000-8578.2017.02.002 |
[2] | CHENG Xiaowei, WANG Chunlin, HUANG Xiaoqing, ZHANG Yong. VEGF Gene Promoter Region-460 T/C Single Nucleotide Polymorphisms and Nasopharyngeal Carcinoma Susceptibility in Guangxi Population[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1125-1128. DOI: 10.3971/j.issn.1000-8578.2014.10.015 |
[3] | MA Qiang, YAN Shanshan, FAN Saijun, SONG Naling. SLC9A3R1 Overexpression Inhibits Proliferation of Breast Cancer Cell Line MDAMB-231[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 892-896. DOI: 10.3971/j.issn.1000-8578.2014.08.008 |
[4] | CUI Jinfeng, WU Sha, LIU Jing, WANG Yuan, ZHANG Xianghong. Damage Effects of Ochratoxin A on Chromosome of Human Gastric Epithelium Cells in vitro[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 541-544. DOI: 10.3971/j.issn.1000-8578.2014.06.007 |
[5] | XIAO Lan, YANG Ji-zhou, KANG Zhao-li. Detection of Uroepithelium Carcinoma of Bladder by Fluorescence in situ Hybridization[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 302-304. DOI: 10.3971/j.issn.1000-8578.2011.03.016 |
[6] | HE Dong-xu, CHAN Ying. The Relationship of GSTT1 Polymorphism and Chromosome 15 Aberration in Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2006, 33(05): 308-310. DOI: 10.3971/j.issn.1000-8578.3364 |
[7] | CAO Su-mei, GUO Xiang, LI Ning-wei, HONG Ming-huang, MIN Hua-qing. The Family Clusting Study of Nasopharyngeal Carcinoma Patients in Guangdong[J]. Cancer Research on Prevention and Treatment, 2006, 33(04): 283-285. DOI: 10.3971/j.issn.1000-8578.3374 |
[8] | TANG Qi-bin, SHI Xue-tao, YI Long-hai, SUN Hua-wen, ZOU Sheng-quan. The Study of Relationship between Inactivation of Tumor Suppressor Gene Cluster Located in Chromosome 9p21 and Progression of Extra-hepatic Bile Duct Cancer[J]. Cancer Research on Prevention and Treatment, 2004, 31(09): 523-525. DOI: 10.3971/j.issn.1000-8578.3163 |
[9] | ZHENG ZHi-jian, HUANG Guo-dong, HE Yan-mei, et al, . Surveillance of high risk pedigree for nasopharyngeal carcinoma in Meizhou[J]. Cancer Research on Prevention and Treatment, 2002, 29(06): 498-499. DOI: 10.3971/j.issn.1000-8578.163 |
[10] | Li Fengrong, . Study on the Micronucleus, Sister Chromatid Exchange (SCE) and Chtromosomal Aberration in lymphocytes of Patients with Lung Cancer[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 347-348. |